https://revistafarmaiq.com/wp-content/uploads/2022/09/mesenquimales_0.jpg3801030Nestor Rodriguezhttps://revistafarmaiq.com/wp-content/uploads/2015/05/Sin-título-1.pngNestor Rodriguez2022-09-20 09:09:002022-09-19 18:22:43HALLAZGO CON CÉLULAS MESENQUIMALES PODRÍA SER ALTERNATIVA PARA DISMINUIR SÍNTOMAS DE PSORIASIS; 2.5 MILLONES DE MEXICANOS LA PADECEN
https://revistafarmaiq.com/wp-content/uploads/2022/09/Cirujias2_0.jpg3801030Nestor Rodriguezhttps://revistafarmaiq.com/wp-content/uploads/2015/05/Sin-título-1.pngNestor Rodriguez2022-09-12 13:29:402022-09-12 13:29:42JOHNSON & JOHNSON MEDTECH PRESENTA EL NUEVO ECOSISTEMA DE CIRUGÍAS DIGITALES
https://revistafarmaiq.com/wp-content/uploads/2022/09/causa_0.jpg3801030Nestor Rodriguezhttps://revistafarmaiq.com/wp-content/uploads/2015/05/Sin-título-1.pngNestor Rodriguez2022-09-01 11:00:102022-09-01 11:21:11PRESENTAN EN MÉXICO NUEVO TRATAMIENTO CONTRA CÁNCER DE PRÓSTATA NO METASTÁSICO RESISTENTE A CASTRACIÓN